Nye doktorgrader
Anders Øglend Bjørnestad disputerte den 14. desember 2017 med avhandlingen “Motor and non-motor challenges in early Parkinson’s disease”.
Vi gratulerer med gjennomført disputas!
Katina Dingtorp Handeland disputerte den 15. desember med avhandlingen “Fatty fish intake, adherence to dietary guidelines and attention Performance. A randomized controlled trial in Norwegian adolescents”.
Vi gratulerer med gjennomført disputas!
Marianna Cortese disputerte den 18. desember 2017 med avhandlingen “The timing of environmental risk factors and prodromal signs of multiple sclerosis”.
Vi gratulerer med gjennomført disputas!
Kommende disputas
Sara Maria Mathisen
Kandidaten utgår fra Klinisk institutt 1
Hovedveileder: Professor Martin Kurz
Medveileder: Professor II Jan Petter Larsen
Prøveforelesning: Torsdag 11. januar 2018 kl. 09.15
Sted: Aulaen, 2. etg. Sydbygg, Stavanger Universitetssjukehus
Oppgitt emne: “Statiners plass i sekundærprofylakse etter hjerneslag – virkningsmekanismer, effekt og bivirkninger”
Disputas: Torsdag 11. januar 2018 kl. 10.30
Sted: Aulaen, 2. etg. Sydbygg, Stavanger Universitetssjukehus
Avhandlingens tittel: “Risk factors influencing long-term survival and nursing home placement in stroke survivors and patients with carotid stenosis”
1. opponent: Professor II Rolf Salvesen, UiT – Norges Arktiske Universitet
2. opponent: Ph.d. Mona Skjelland, Oslo Universitetssykehus
3. medlem av komiteen: Professor Roald Omdal, Universitetet i Bergen
Disputasen blir ledet av professor II Jon Arne Søreide.
Åpent for alle interesserte
PhD course- CCBIO903
You still have the opportunity to register for the CCBIO903 course, Cancer Research: Ethical, economical and societal aspects: 29 January-2 February and 19-22 February 2018.
CCBIO903 is a 5 ECTS credits PhD course within CCBIO’s Research School for Cancer Studies (RSCS). All PhD candidates within cancer research (in Norway and abroad) are welcome to apply. Other cancer researchers as well as students at the Medical Student Research Programme at the UiB are also welcome.
Cancer researchers and clinicians face important questions and dilemmas every day:
How can we deal with the uncertainties in the lab, while maintaining the quality of our science?
Which drug is more suited to a patient?
How can medical science contribute to debates on what is good for society?
How can economic models help guide health care resource allocation?
The course addresses these questions, and will focus on aspects such as how to assess the cost-effectiveness of cancer biomarkers, how to make medical decisions when surrounded by risks, uncertainties and even ignorance, what the ‘good life’ can actually mean, and what the future may hold for cancer research. PhD candidates will be invited to reflect upon the ethical, economic and social aspects of their own research, in interaction with scholars and other students.
Read more here. Also see poster.
Registration: Registration for vacant places until 25 January 2018. Use this registration link.
Instructors include John Cairns and Kelly Seo (CCBIO & London School of Hygiene and Tropical Medicine); Ole F. Norheim and Eirik Tranvåg (CCBIO & the Dept. of Global Public Health and Primary Care, UiB); Caroline Engen and Elisabeth Wik (CCBIO); and Roger Strand and Anne Blanchard (CCBIO & Centre for the Study of the Sciences and the Humanities, UiB).